Integrated systems toxicology identifies TCDD-responsive targets linked to immune dysregulation and treatment response in psoriasis - Top-Institutions - MDSpire

Integrated systems toxicology identifies TCDD-responsive targets linked to immune dysregulation and treatment response in psoriasis

  • By

  • Xuan Zhang

  • Yankun Zhang

  • Yanling He

  • May 29, 2026

  • 0 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai

    New York, New York

    Key Differentiators

    • Dermatology

  • #2

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, Pennsylvania

    Key Differentiators

    • Dermatology

  • #3

    US EPA
    US EPA

    Washington, DC

    Key Differentiators

    • Environmental Health

  • #4

    Human Toxome Project
    Human Toxome Project

    Not specified, Not specified

    Key Differentiators

    • Toxicology

  • #5

    US National Research Council
    US National Research Council

    Washington, DC

    Key Differentiators

    • Research Council

Original Source(s)

Integrated systems toxicology identifies TCDD-responsive targets linked to immune dysregulation and treatment response in psoriasis

  • by Xuan Zhang, Yankun Zhang, Yanling He

  • May 29, 2026

Related Content

Bimekizumab in Psoriasis: 3-Year Outcomes

Investigators compare patient-reported symptoms and quality-of-life outcomes vs secukinumab.

Top 10 Evidence-Based Essentials in Dermatology

A structured framework of guidelines, trials, therapies, and tools used in clinical practice

Three-Year Outcomes Reported by Patients Using Bimekizumab for Plaque Psoriasis: Findings from the BE RADIANT Randomized Trial